Zydus Lifesciences Ltd Board of Directors
Board of Directors at Zydus Lifesciences Ltd
Independent Director
Independent Director
Independent Director
Company Sec. & Compli. Officer
Whole-time Director
Key Highlights
- Pankaj R Patel joins the board as Chairman(Non Exe)&Dir(Non-Ind), in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sharvil P Patel joins the board as Executive Director & MD, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ganesh N Nayak joins the board as Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Mukesh Patel joins the board as Non-Exec & Non-Independent Dir, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Bhadresh K Shah joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Zydus Lifesciences Ltd
NSE: ZYDUSLIFE
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 23 Jul 2026 | 1113.6 |
| 22 Jul 2026 | 1129.75 |
| 21 Jul 2026 | 1143.65 |
| 20 Jul 2026 | 1146.65 |
| 17 Jul 2026 | 1142.75 |
| 16 Jul 2026 | 1153.5 |
| 15 Jul 2026 | 1154.4 |
| 14 Jul 2026 | 1133.85 |
| 13 Jul 2026 | 1131.05 |
| 10 Jul 2026 | 1150.5 |
Company Fundamentals for Zydus Lifesciences Ltd
Market Cap
111,082 Cr
EPS
54.5
P/E Ratio (TTM)
20.7
P/B Ratio (TTM)
4.2
Day’s High
1129.2
Day’s Low
1106.7
DTE
0.5
ROE
18.6
52 Week High
1181.0
52 Week Low
835.85
ROCE
17.4
Market Price of Zydus Lifesciences Ltd
1M
1Y
3Y
5Y
Zydus Lifesciences Ltd News Hub
Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr
Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quareter ended 3
Read more
09 Aug 24
Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as a
Read more
09 Aug 24
Zydus receives USFDA approval for Valbenazine Capsules
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (
Read more
09 Aug 24
Zydus Lifesciences Ltd soars 1.83%, rises for third straight session
Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1296.
Read more
08 Aug 24
Document
Concalls
